Janus Capital Management LLC Decreases Position in Mead Johnson Nutrition CO (MJN)

Janus Capital Management LLC decreased its stake in Mead Johnson Nutrition CO (NYSE:MJN) by 93.8% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 15,458 shares of the company’s stock after selling 233,397 shares during the period. Janus Capital Management LLC’s holdings in Mead Johnson Nutrition CO were worth $1,377,000 as of its most recent filing with the SEC.

Receive News & Ratings for Mead Johnson Nutrition CO Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.

Other large investors have also modified their holdings of the company. Meeder Asset Management Inc. acquired a new stake in shares of Mead Johnson Nutrition CO during the first quarter valued at approximately $106,000. Oppenheimer Asset Management Inc. acquired a new stake in shares of Mead Johnson Nutrition CO during the first quarter valued at approximately $120,000. Creative Planning boosted its stake in shares of Mead Johnson Nutrition CO by 4.3% in the first quarter. Creative Planning now owns 2,169 shares of the company’s stock valued at $193,000 after buying an additional 89 shares in the last quarter. Fiduciary Trust Co. acquired a new stake in shares of Mead Johnson Nutrition CO during the first quarter valued at approximately $205,000. Finally, St. Louis Trust Co acquired a new stake in shares of Mead Johnson Nutrition CO during the first quarter valued at approximately $212,000. Institutional investors own 88.40% of the company’s stock.

Shares of Mead Johnson Nutrition CO (MJN) opened at 89.98 on Monday. The stock has a 50 day moving average of $89.62 and a 200-day moving average of $84.34. Mead Johnson Nutrition CO has a 12 month low of $69.25 and a 12 month high of $94.40.

COPYRIGHT VIOLATION WARNING: This article was originally published by [[site]] and is the sole property of of [[site]]. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at [[permalink]].

Several equities research analysts have recently commented on the stock. Canaccord Genuity reiterated a “speculative buy” rating on shares of Mead Johnson Nutrition CO in a research report on Wednesday, July 5th. BidaskClub upgraded shares of Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. BMO Capital Markets restated a “hold” rating and set a $90.00 price objective on shares of Mead Johnson Nutrition CO in a report on Thursday, June 15th. Finally, Zacks Investment Research cut shares of Mead Johnson Nutrition CO from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Two investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. The company presently has an average rating of “Hold” and an average price target of $83.18.

Mead Johnson Nutrition CO Company Profile

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.